Yearly Archives: 2024

MHRA Class 3 Medicines Recall: Evorel Sequi (Theramex HQ UK Ltd) Drug alert number: EL (24)A/41 Date issued: 12 September 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines defect information notice for: Evorel Sequi (Theramex HQ UK Ltd) Company name:Theramex HQ UK Ltd Product name: Evorel Sequi, PL 49105/0010 [...]

The post MHRA Class 3 Medicines Recall: Evorel Sequi (Theramex HQ UK Ltd) appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the reimbursement prices for Oestrogel® and Testogel® preparations dispensed in August 2024. On 1 August 2024, there was an increase in the NHS list prices of Oestrogel® and Testogel® preparations manufactured by Besins [...]

The post Oestrogel® and Testogel® – reimbursement price changes for August 2024 appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices of Nutrison® water for gastroenteral feeds dispensed from January to July 2024. The list price of Nutrison® water for gastroenteral feeds manufactured by Nutricia Ltd had recently increased but [...]

The post Retrospective reimbursement price adjustments for Nutrison® water for gastroenteral feeds appeared first on Community Pharmacy England.

New Original Pack Dispensing (OPD) rules, central procurement of certain vaccinations for community pharmacies, and changes to the market entry application process are being introduced in The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2024. These PLPS amendment regulations were laid this week on Tuesday 3 September and are due [...]

The post Amendments to pharmacy regulations to introduce OPD +/- 10% dispensing appeared first on Community Pharmacy England.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued precautionary guidance regarding the of use of valproate in men. This follows results from a retrospective observational study which indicated a possible association between valproate use by men around the time of conception and an increased risk of neurodevelopmental disorders in their children.  Male patients [...]

The post MHRA Drug Safety Update: Valproate use in men appeared first on Community Pharmacy England.